Yecuris FRG: humanized animals and human hepatocytes platform for your next great discovery.
  • FRG® PLATFORM
    • Platform Overview
    • FRG® KO Mice
    • Fresh Hepatocytes
    • Reagents
  • APPLICATION AREAS
    • Gene & Cell Therapy
    • NASH & NAFLD
    • Infectious Diseases
    • DMPK
    • Custom Transplantation
  • RESEARCH SERVICES
  • COMPANY
    • About Us
    • Publications
    • Careers
    • Upcoming Events
    • Contact Us
  • SCHEDULE A MEETING
Select Page

ebook-40

by Greg Bial | Jul 15, 2019

Recent Posts

  • Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice.
  • Seattle BioMed and Yecuris Team Up to Identify Novel Vaccine and Drug Candidates for Malaria
  • Taconic and Yecuris Corporation Announce Strategic Marketing Alliance

Recent Comments

    Archives

    • February 2019
    • June 2014
    • February 2013

    Categories

    • Press Releases
    • Publications

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Recent Posts

    • Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice.
    • Seattle BioMed and Yecuris Team Up to Identify Novel Vaccine and Drug Candidates for Malaria
    • Taconic and Yecuris Corporation Announce Strategic Marketing Alliance

    FRG® PLATFORM

    FRG® KO Mice

    Fresh Hepatocytes

    Reagents

    APPLICATION AREAS

    Gene & Cell Therapy

    Infectious Disease

    NASH

    DMPK

    YECURIS

    Research Services

    About Us

    Publications

    Contact Us

    FRG® KO UPDATES

    • Facebook
    • Twitter
    Yecuris Corporation | P.O. Box 4645, Tualatin, OR 97062 | 503.352.4663     Privacy Policy    Terms & Conditions
    ©2020 Yecuris Corporation. All rights reserved. Yecuris™, FRG®, MetAbArray™, HepaCur™ and CuRx™ are trademarks of Yecuris Corporation.